Process View
The directed movement of a motile cell or organism towards a higher concentration of a chemical.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive chemotaxis"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
EGFR | epidermal growth factor receptor | 1.000 | ||
PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.978 | ||
FGFR2 | fibroblast growth factor receptor 2 | 0.966 | ||
PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.963 | Human | |
VEGFA | vascular endothelial growth factor A | 0.949 | ||
FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.920 | Human | |
PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.920 | Human | |
ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.883 | ||
TEK | TEK tyrosine kinase, endothelial | 0.852 | ||
CCR5 | chemokine (C-C motif) receptor 5 | 0.797 | ||
DPP4 | dipeptidyl-peptidase 4 | 0.796 | ||
CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.722 | ||
MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.676 | ||
PLCG1 | phospholipase C, gamma 1 | 0.661 | ||
FGFR1 | fibroblast growth factor receptor 1 | 0.650 | ||
PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.580 | ||
SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.567 | ||
CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.560 | ||
LAT | linker for activation of T cells | 0.549 | ||
IL8 | interleukin 8 | 0.548 | ||
FGF1 | fibroblast growth factor 1 (acidic) | 0.546 | Human | |
ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.520 | ||
PTPRC | protein tyrosine phosphatase, receptor type, C | 0.474 | ||
SEMA4A | sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A | 0.373 | Fly | |
CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.370 | Human | |
CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.369 | ||
GAB1 | GRB2-associated binding protein 1 | 0.348 | ||
NRP1 | neuropilin 1 | 0.317 | Mouse | |
CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.307 | Human | |
CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.296 | Human | |
CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.282 | Human | |
CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.235 | Human | |
KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.224 | ||
CCL8 | chemokine (C-C motif) ligand 8 | 0.223 | Human | |
CCL2 | chemokine (C-C motif) ligand 2 | 0.222 | Human | |
CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.217 | ||
PLXNB1 | plexin B1 | 0.211 | Human | |
CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.178 | Human | |
CCL5 | chemokine (C-C motif) ligand 5 | 0.172 | ||
NTRK2 | neurotrophic tyrosine kinase, receptor, type 2 | 0.157 | Human | |
BMPR1A | bone morphogenetic protein receptor, type IA | 0.148 | ||
FN1 | fibronectin 1 | 0.143 | ||
CCL20 | chemokine (C-C motif) ligand 20 | 0.141 | Human | |
GRB7 | growth factor receptor-bound protein 7 | 0.130 | ||
NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 0.128 | Human | |
CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.125 | Human | |
CALCOCO2 | calcium binding and coiled-coil domain 2 | 0.119 | ||
CCL4 | chemokine (C-C motif) ligand 4 | 0.118 | Human | |
CNKSR2 | connector enhancer of kinase suppressor of Ras 2 | 0.114 | ||
APC | adenomatous polyposis coli | 0.114 | ||
PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.111 | ||
DSG2 | desmoglein 2 | 0.111 | ||
PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.107 | ||
SOS1 | son of sevenless homolog 1 (Drosophila) | 0.105 | ||
FGF10 | fibroblast growth factor 10 | 0.105 | ||
RND1 | Rho family GTPase 1 | 0.105 | ||
GHR | growth hormone receptor | 0.099 | ||
ARHGEF11 | Rho guanine nucleotide exchange factor (GEF) 11 | 0.096 | ||
IL6 | interleukin 6 (interferon, beta 2) | 0.094 | ||
FGA | fibrinogen alpha chain | 0.093 | ||
TGIF1 | TGFB-induced factor homeobox 1 | 0.090 | ||
GAS6 | growth arrest-specific 6 | 0.089 | ||
CCL19 | chemokine (C-C motif) ligand 19 | 0.086 | Human | |
CCL3 | chemokine (C-C motif) ligand 3 | 0.079 | ||
CAV1 | caveolin 1, caveolae protein, 22kDa | 0.075 | ||
IL1B | interleukin 1, beta | 0.071 | ||
PLAU | plasminogen activator, urokinase | 0.068 | Human | |
VCAM1 | vascular cell adhesion molecule 1 | 0.066 | ||
PLAT | plasminogen activator, tissue | 0.065 | Human | |
PGF | placental growth factor | 0.064 | Human | |
PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.064 | ||
FGF7 | fibroblast growth factor 7 | 0.062 | ||
CCR7 | chemokine (C-C motif) receptor 7 | 0.062 | ||
PDGFC | platelet derived growth factor C | 0.061 | ||
PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.061 | ||
CSNK1A1 | casein kinase 1, alpha 1 | 0.061 | ||
CCL7 | chemokine (C-C motif) ligand 7 | 0.060 | Human | |
CCR2 | chemokine (C-C motif) receptor 2 | 0.059 | ||
S100B | S100 calcium binding protein B | 0.051 | ||
DPYSL4 | dihydropyrimidinase-like 4 | 0.050 | ||
CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.050 | Human | |
ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.049 | ||
CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.048 | ||
CCR1 | chemokine (C-C motif) receptor 1 | 0.047 | ||
PLXND1 | plexin D1 | 0.046 | Human | |
ALB | albumin | 0.046 | ||
SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.044 | ||
UBD | ubiquitin D | 0.042 | ||
CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | 0.042 | ||
MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.042 | ||
ANGPT2 | angiopoietin 2 | 0.041 | ||
CTNNA1 | catenin (cadherin-associated protein), alpha 1, 102kDa | 0.041 | ||
PLXNB2 | plexin B2 | 0.040 | Human | |
PDGFA | platelet-derived growth factor alpha polypeptide | 0.040 | Human | |
CCL13 | chemokine (C-C motif) ligand 13 | 0.039 | Human | |
TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.039 | ||
YWHAB | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide | 0.037 | ||
CCL14 | chemokine (C-C motif) ligand 14 | 0.037 | Human | |
CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.037 | Human | |
IFNG | interferon, gamma | 0.036 | ||
CXCL6 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | 0.036 | Human | |
HSPG2 | heparan sulfate proteoglycan 2 | 0.036 | ||
ANGPT1 | angiopoietin 1 | 0.035 | ||
NTF4 | neurotrophin 4 | 0.034 | Human | |
NGF | nerve growth factor (beta polypeptide) | 0.034 | Human | |
TSC1 | tuberous sclerosis 1 | 0.034 | ||
OSMR | oncostatin M receptor | 0.034 | ||
PTPRB | protein tyrosine phosphatase, receptor type, B | 0.033 | Human | |
VEGFC | vascular endothelial growth factor C | 0.033 | ||
NRP2 | neuropilin 2 | 0.033 | ||
PSEN1 | presenilin 1 | 0.032 | ||
FYN | FYN oncogene related to SRC, FGR, YES | 0.032 | ||
PKP4 | plakophilin 4 | 0.031 | ||
FLNA | filamin A, alpha | 0.031 | ||
MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.031 | ||
FGF8 | fibroblast growth factor 8 (androgen-induced) | 0.030 | Rat | |
MICA | MHC class I polypeptide-related sequence A | 0.029 | ||
IL7R | interleukin 7 receptor | 0.028 | ||
ITGAL | integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) | 0.027 | ||
HGF | hepatocyte growth factor (hepapoietin A; scatter factor) | 0.027 | ||
LDLR | low density lipoprotein receptor | 0.027 | ||
BDNF | brain-derived neurotrophic factor | 0.026 | Human | |
PTMA | prothymosin, alpha | 0.026 | ||
SLA | Src-like-adaptor | 0.025 | ||
DARC | Duffy blood group, chemokine receptor | 0.025 | ||
INHBA | inhibin, beta A | 0.024 | ||
TMSB10 | thymosin beta 10 | 0.024 | ||
MST1R | macrophage stimulating 1 receptor (c-met-related tyrosine kinase) | 0.024 | Human | |
TIMP1 | TIMP metallopeptidase inhibitor 1 | 0.024 | ||
CCL22 | chemokine (C-C motif) ligand 22 | 0.024 | Human | |
NTF3 | neurotrophin 3 | 0.024 | ||
KITLG | KIT ligand | 0.024 | ||
COL5A1 | collagen, type V, alpha 1 | 0.023 | ||
BCAR1 | breast cancer anti-estrogen resistance 1 | 0.022 | ||
CD69 | CD69 molecule | 0.021 | ||
CD22 | CD22 molecule | 0.021 | ||
CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.021 | ||
DPT | dermatopontin | 0.021 | ||
CCR4 | chemokine (C-C motif) receptor 4 | 0.020 | Rat | |
HMGB2 | high mobility group box 2 | 0.020 | ||
TPM4 | tropomyosin 4 | 0.020 | ||
COL6A1 | collagen, type VI, alpha 1 | 0.020 | ||
RANBP9 | RAN binding protein 9 | 0.020 | ||
ROBO4 | roundabout homolog 4, magic roundabout (Drosophila) | 0.020 | ||
CD2 | CD2 molecule | 0.019 | ||
DUT | deoxyuridine triphosphatase | 0.019 | ||
ITGB4 | integrin, beta 4 | 0.019 | ||
PLAUR | plasminogen activator, urokinase receptor | 0.019 | ||
IL2RB | interleukin 2 receptor, beta | 0.019 | ||
VKORC1 | vitamin K epoxide reductase complex, subunit 1 | 0.019 | ||
FGF2 | fibroblast growth factor 2 (basic) | 0.018 | ||
AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.018 | Rat | |
CH25H | cholesterol 25-hydroxylase | 0.018 | ||
TXN | thioredoxin | 0.018 | ||
ADAMDEC1 | ADAM-like, decysin 1 | 0.018 | ||
SERPINC1 | serpin peptidase inhibitor, clade C (antithrombin), member 1 | 0.017 | ||
CD163 | CD163 molecule | 0.017 | ||
PXN | paxillin | 0.017 | ||
BTRC | beta-transducin repeat containing | 0.017 | ||
SRGN | serglycin | 0.017 | ||
KNG1 | kininogen 1 | 0.017 | ||
SELE | selectin E | 0.017 | ||
SLIT2 | slit homolog 2 (Drosophila) | 0.016 | ||
WNT1 | wingless-type MMTV integration site family, member 1 | 0.016 | ||
ITGA6 | integrin, alpha 6 | 0.016 | ||
ANXA2 | annexin A2 | 0.016 | ||
PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.016 | ||
CDH3 | cadherin 3, type 1, P-cadherin (placental) | 0.016 | Human | |
EMD | emerin | 0.016 | ||
RGS16 | regulator of G-protein signaling 16 | 0.016 | ||
CD40LG | CD40 ligand | 0.016 | ||
TGFB2 | transforming growth factor, beta 2 | 0.016 | ||
FPR3 | formyl peptide receptor 3 | 0.016 | ||
CD63 | CD63 molecule | 0.016 | ||
PF4 | platelet factor 4 | 0.016 | ||
MSC | musculin | 0.016 | ||
SH3RF1 | SH3 domain containing ring finger 1 | 0.015 | ||
CDH11 | cadherin 11, type 2, OB-cadherin (osteoblast) | 0.015 | ||
TNF | tumor necrosis factor | 0.015 | ||
DCN | decorin | 0.015 | ||
WDYHV1 | WDYHV motif containing 1 | 0.015 | ||
CLEC10A | C-type lectin domain family 10, member A | 0.015 | ||
CXCR3 | chemokine (C-X-C motif) receptor 3 | 0.015 | ||
TFPI2 | tissue factor pathway inhibitor 2 | 0.015 | ||
ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.015 | ||
DSP | desmoplakin | 0.015 | ||
CTGF | connective tissue growth factor | 0.015 | ||
CRMP1 | collapsin response mediator protein 1 | 0.015 | ||
WIPI1 | WD repeat domain, phosphoinositide interacting 1 | 0.015 | ||
RGS1 | regulator of G-protein signaling 1 | 0.015 | ||
HLA-DRA | major histocompatibility complex, class II, DR alpha | 0.015 | ||
DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.015 | ||
TIE1 | tyrosine kinase with immunoglobulin-like and EGF-like domains 1 | 0.015 | ||
SPRY4 | sprouty homolog 4 (Drosophila) | 0.015 | ||
LAMP3 | lysosomal-associated membrane protein 3 | 0.015 | ||
VCL | vinculin | 0.014 | ||
STC1 | stanniocalcin 1 | 0.014 | ||
CTTN | cortactin | 0.014 | ||
ENO1 | enolase 1, (alpha) | 0.014 | ||
S100A4 | S100 calcium binding protein A4 | 0.014 | ||
PTPRD | protein tyrosine phosphatase, receptor type, D | 0.014 | ||
FLT4 | fms-related tyrosine kinase 4 | 0.014 | Human | |
TRAF3IP3 | TRAF3 interacting protein 3 | 0.014 | ||
LGALS1 | lectin, galactoside-binding, soluble, 1 | 0.014 | Human | |
TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.013 | ||
KIAA1199 | KIAA1199 | 0.013 | ||
CA12 | carbonic anhydrase XII | 0.013 | ||
ICAM1 | intercellular adhesion molecule 1 | 0.013 | ||
CSK | c-src tyrosine kinase | 0.013 | ||
CDC34 | cell division cycle 34 homolog (S. cerevisiae) | 0.013 | ||
CD83 | CD83 molecule | 0.013 | ||
CCL11 | chemokine (C-C motif) ligand 11 | 0.013 | Human | |
FGFBP1 | fibroblast growth factor binding protein 1 | 0.013 | ||
IL1A | interleukin 1, alpha | 0.012 | ||
EVI2A | ecotropic viral integration site 2A | 0.012 | ||
HMGB1 | high mobility group box 1 | 0.012 | Human | |
CCR3 | chemokine (C-C motif) receptor 3 | 0.012 | ||
TCF7L2 | transcription factor 7-like 2 (T-cell specific, HMG-box) | 0.012 | ||
NUCKS1 | nuclear casein kinase and cyclin-dependent kinase substrate 1 | 0.012 | ||
LAMC2 | laminin, gamma 2 | 0.012 | ||
WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 0.012 | ||
TLN1 | talin 1 | 0.012 | ||
TNC | tenascin C | 0.012 | ||
STX8 | syntaxin 8 | 0.012 | ||
ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.012 | ||
NGFR | nerve growth factor receptor | 0.012 | ||
TTR | transthyretin | 0.012 | ||
DST | dystonin | 0.012 | ||
SHC3 | SHC (Src homology 2 domain containing) transforming protein 3 | 0.012 | ||
IL11 | interleukin 11 | 0.012 | ||
C7 | complement component 7 | 0.012 | ||
IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.012 | ||
PLA2G7 | phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) | 0.012 | ||
IDO1 | indoleamine 2,3-dioxygenase 1 | 0.012 | ||
FGFR3 | fibroblast growth factor receptor 3 | 0.012 | ||
CXCR6 | chemokine (C-X-C motif) receptor 6 | 0.012 | ||
A1BG | alpha-1-B glycoprotein | 0.011 | ||
PVR | poliovirus receptor | 0.011 | ||
CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.011 | ||
LAMB3 | laminin, beta 3 | 0.011 | ||
ANP32E | acidic (leucine-rich) nuclear phosphoprotein 32 family, member E | 0.011 | ||
RICTOR | RPTOR independent companion of MTOR, complex 2 | 0.011 | ||
PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.011 | ||
IRF8 | interferon regulatory factor 8 | 0.011 | ||
PTK2B | PTK2B protein tyrosine kinase 2 beta | 0.011 | ||
STAB2 | stabilin 2 | 0.011 | ||
CSF1 | colony stimulating factor 1 (macrophage) | 0.011 | ||
MMP7 | matrix metallopeptidase 7 (matrilysin, uterine) | 0.011 | ||
WNT2 | wingless-type MMTV integration site family member 2 | 0.011 | ||
MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.011 | ||
MMP10 | matrix metallopeptidase 10 (stromelysin 2) | 0.011 | ||
IDE | insulin-degrading enzyme | 0.011 | ||
OLR1 | oxidized low density lipoprotein (lectin-like) receptor 1 | 0.011 | ||
SRPX | sushi-repeat containing protein, X-linked | 0.011 | ||
CD4 | CD4 molecule | 0.011 | ||
SERPINF2 | serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 | 0.011 | ||
MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.011 | ||
IL18R1 | interleukin 18 receptor 1 | 0.011 | ||
KLRD1 | killer cell lectin-like receptor subfamily D, member 1 | 0.011 | ||
TLR2 | toll-like receptor 2 | 0.010 | ||
XCL1 | chemokine (C motif) ligand 1 | 0.010 | Human | |
PTHLH | parathyroid hormone-like hormone | 0.010 | ||
TCF4 | transcription factor 4 | 0.010 | ||
C2 | complement component 2 | 0.010 | ||
MOBKL2B | MOB1, Mps One Binder kinase activator-like 2B (yeast) | 0.010 | ||
NKG7 | natural killer cell group 7 sequence | 0.010 | ||
IL2RG | interleukin 2 receptor, gamma | 0.010 | ||
GLIS2 | GLIS family zinc finger 2 | 0.010 | ||
SYK | spleen tyrosine kinase | 0.010 | ||
FGG | fibrinogen gamma chain | 0.010 | ||
ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 0.010 | Rat | |
SLAMF8 | SLAM family member 8 | 0.010 | ||
BCL2A1 | BCL2-related protein A1 | 0.010 | ||
SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.010 |